Medtronic plc. (MDT)
| Market Cap | 172.71B |
| Revenue (ttm) | 27.93B |
| Net Income (ttm) | 2.89B |
| Shares Out | 1.35B |
| EPS (ttm) | 2.26 |
| PE Ratio | 56.79 |
| Forward PE | 22.32 |
| Dividend | $2.28 |
| Dividend Yield | 1.78% |
| Trading Day | April 20 |
| Last Price | $128.28 |
| Previous Close | $126.13 |
| Change ($) | 2.15 |
| Change (%) | 1.70% |
| Day's Open | 125.91 |
| Day's Range | 125.79 - 128.42 |
| Day's Volume | 5,411,114 |
| 52-Week Range | 86.32 - 128.42 |
IN.PACT AV Access Trial 24 Month Results Presented as a Podium First at Charing Cross Symposium DUBLIN and LONDON, April 20, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical t...
Edina, MN, based Investment company Accredited Investors Inc. (Current Portfolio) buys BTC iShares MSCI EAFE Value ETF, iShares Russell 2000 Value ETF, iShares MSCI All Country Asia ex Japan Index Fund,...
If you think cyberattacks are scary, what if those attacks were directed at your cardiac pacemaker? Medtronic, a medical device company, has been in hot water over the last couple of years because its p...
Medtronic's (MDT) recently introduced Medtronic Extended infusion set with longer wearability enhances convenience and comfort, thus improving diabetes care.
The new Micra AV leadless pacemaker proves that good things come in small packages.
DUBLIN, April 14, 2021 /PRNewswire/ -- Medtronic plc (NYSE: MDT), the global leader in medical technology, today introduced in select European countries the Medtronic Extended infusion set — the first a...
These 3D stocks have proven to be instrumental in improving the quality of healthcare outcomes The post 3 3D Stocks That Can Advance the World of Healthcare appeared first on InvestorPlace. More From In...
Medtronic's (MDT) GI Genius Module is the only commercially available computer-aided detection system which uses artificial intelligence to identify colorectal polyploid.
- The GI Genius™ Module Assists Physicians in Detecting Pre-Cancerous Growths; Potentially Addressing 19 Million Colonoscopies Annually - Transformative AI Colorectal Cancer Prevention Platform Expands...
Medtronic's (MDT) ventilator sales are robust and prospects of the Diabetes arm remain strong amid the pandemic.
MINNEAPOLIS, April 7, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced its ongoing commitment to health equity for people of color living with diab...
Final Trades: Hanesbrands, Norwegian Cruise Line, Medtronic & more
The "Halftime Report" traders give their top picks to watch for the second half.
Investors continue to be optimistic about Medtronic (MDT) on its slew of product launches and regulatory approvals.
This is a stable investment you can buy and forget about.
DUBLIN, March 26, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received U.S. Food and Drug Administration (FDA) approval for its Harmony...
Medtronic (MDT) reported earnings 30 days ago. What's next for the stock?
Medtronic looks attractive at current levels of $117, as it is up 60% from the levels it was at on March 23, 2020, when broader markets made a bottom due to the spread of Covid-19. This marks an underpe...
This SenSight system according to Medtronic (MDT), is set to enhance detection of local field potentials (LFPs).
This First-of-its-Kind Directional Lead Combines the Benefits of Directionality with the Power of Sensing DUBLIN, March 22, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical te...
Here are a few diabetes-centric MedTech stocks, ABT, NVO, MDT, PODD and TNDM, which investors can focus on to reap profits in the new normal.
Just like that, we are less than two weeks from the end of the first quarter. While it has been a very positive one for investors, the rise in interest rates has brought in much higher volatility and ha...
This latest development is expected to contribute to Medtronic's (MDT) pain therapy business in the coming months.
We think that Medtronic currently is a better pick compared to Intuitive Surgical. MDT stock trades at about 5.7x trailing revenues, compared to around 18.5x for ISRG.
DUBLIN, March 17, 2021 /PRNewswire/ -- Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced the U.S. Food and Drug Administration (FDA) has approved revised commercial lab...
NEX: CHIP CALGARY, AB, March 12, 2021 /PRNewswire/ - Health Logic Interactive Inc. ("Health Logic" or the "Company") (NEX: CHIP), is pleased to announce the hiring of Mr. David Barthel, as the Chief Exe...
DUBLIN, March 8, 2021 /PRNewswire/ -- The board of directors of Medtronic plc (NYSE: MDT) on Friday, March 5, 2021, approved the fiscal year 2021 fourth quarter cash dividend of $0.58 per ordinary share...
The S&P 500 stocks saw their aggregate trailing 12-month real revenue per share increase at a compound annual growth rate of nearly 2% over the past five years. The share price of the benchmark index fo...
These four MedTech stocks -- ABT, JNJ, MDT and MASI -- are expected to gain enormously from FDA's SaMD Action Plan 2021.
When the market is expensive and overbought like the current one is, it is very important to stay with companies that not only have solid earnings potential but also have upcoming catalysts that can hel...
Medtronic's (MDT) REVERSE analysis highlights the role played by CRT to slow the progression of HF, thus reinforcing the strong clinical evidence supporting CRT.
Investors continue to be optimistic about Medtronic (MDT) on slew of product launches and regulatory approvals.
The latest back-to-back incidents will, undoubtedly, create a major drag in Medtronic's (MDT) VAD performance.
The FDA has classified another recall of Medtronic Plc's (NYSE: MDT) HeartWare HVAD ventricular assist device as a Class I event in light of the potential for serious harm. Medtronic is recalling 157 HV...
DUBLIN, March 2, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced new results from the landmark REVERSE trial, evaluating outcomes of cardiac resyn...
In Coronary, the ongoing issue related to the China drug-eluting stent national tender, Medtronic (MDT) is currently winning share globally.
Final Trades: ROKU, MDT, SONO & XHB
The Fast Money traders make their final trades of the week.
Medtronic (MDT) procedure volumes hurt by resurgence of COVID-19 cases despite increased demand for related diagnostics and therapies.
Medtronic CEO Geoff Martha on Q3 EPS beat, pipeline and more
Medtronic reported a quarterly profit above Wall Street estimates, helped in part by stronger demand for ventilators amid the pandemic. Medtronic CEO Geoff Martha joined Tuesday "Squawk on the Street" t...
Medtronic (MDT) delivered earnings and revenue surprises of 12.17% and -0.03%, respectively, for the quarter ended January 2021. Do the numbers hold clues to what lies ahead for the stock?
Shares of Medtronic (NYSE:MDT) fell 0.2% in pre-market trading after the company reported Q3 results. Quarterly Results Earnings per share decreased 10.42% over the past year to $1.29, which beat the es...
- Q3 Revenue of $7.8 Billion Increased 0.8% as Reported and Decreased 1.0% Organically - Q3 GAAP Diluted EPS of $0.94; Q3 Non-GAAP Diluted EPS of $1.29 DUBLIN, Feb. 23, 2021 /PRNewswire/ -- Medtronic pl...
Medtronic stock is scheduled to report its fiscal third-quarter results on Tuesday, February 23. We expect Medtronic to likely post revenues in-line, and earnings above the consensus estimates.
Medtronic (MDT) expects this updated labeling with wider procedural options and shorter wait time to improve patient access to MRI exams and add more flexibility for MRI providers.
Health care companies may not be at the front of mind when thinking of stocks with dividends, but these three are winners. The post 3 High-Quality Health Care Companies With Recession-Proof Dividends ap...
Medtronic's (MDT) recent surgeries reach a milestone in the transformation of spine surgery as a result of increased accuracy and minimally invasive technique.
The FDA has approved expanded MRI labeling of Medtronic plc's (NYSE: MDT) InterStim II and InterStim Micro sacral neuromodulation (SNM) systems that use SureScan MRI leads. The updated MRI Guidelines al...
Medtronic (MDT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
About MDT
Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. It operates through four segments: Cardiac and Vascular Group, Minimally Invasive Therapies Group, Restorative Therapies Group, and Diabetes Group. The Cardiac and Vascular Group segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; AF ablation products; insertable cardiac monitor systems; mechanical circulatory support; TYRX... [Read more...]
| Industry Medical Devices | Founded 1949 |
| CEO Geoffrey Martha | Employees 90,000 |
| Stock Exchange NYSE | Ticker Symbol MDT |
Financial Performance
In 2020, Medtronic's revenue was $28.91 billion, a decrease of -5.38% compared to the previous year's $30.56 billion. Earnings were $4.79 billion, an increase of 3.41%.
Analyst Forecasts
According to 27 analysts, the average rating for Medtronic stock is "Buy." The 12-month stock price forecast is 134.31, which is an increase of 4.70% from the latest price.